Agencies
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Agencies | Published : June 5, 2016 6:22 PM IST
Immune cells of older people are less likely to be effective at fending off the hepatitis C virus (HCV), finds a new study suggesting a correlation between ageing and the effectiveness of T-cells. Using a novel technique called iTAST (in situ TCR affinity and sequence test), the team measured a group of donors' T-cell's affinity -- a physical parameter that determines how well the immune cell receptors recognise and bind to their antigens -- for HCV.
If a person has low-affinity T-cells for a specific virus, the body won't mount an effective fight against the virus. However, high-affinity T-cells can launch strong fights against diseases and illnesses such as cancer and diabetes. T-cell affinity is a parameter that can gauge how healthy your immune system is toward a specific antigen, said lead author Jenny Jiang, Assistant Professor, at University of Texas, in the US.
The findings showed a stark difference between the HCV-specific T-cells of older and younger donors. The study found that as one grows older, the T-cells capable of recognising some of the viruses become progressively lower in affinity, Jiang added. iTAST is the first technique capable of retrieving and measuring the affinity of a large volume of T-cells and their correlated receptor sequences from an individual, the researchers said in the paper published in the journal Science Translational Medicine.
What we are doing is isolating T-cells from a patient. They are the patient's own cells, so iTAST is potentially a way to isolate safe high-affinity T-cells for adoptive immunotherapy, explained Shuqi Zhang, Graduate Student at University of Texas. iTAST's ability to identify and retrieve a person's high-affinity T-cells could benefit immunotherapy and vaccine development, resulting in improved personalised medicine and therapies, the researchers noted.
Source: IANS
Image source: Shutterstock
